Abstract
Background: The objective of our study was to compare two different central nervous system penetration- effectiveness (CPE) scores for the prediction of cognitive dysfunction in HIV-infected patients. Methods: We performed a cross-sectional single cohort study, consecutively enrolled during routine outpatient visits. HIV-infected subjects on antiretroviral therapy with plasma HIV RNA+ T-cell count, orCPE rank did not show an association with cognitive performance ( P=0.704). By contrast, patients with revCPE rank ≥6 (OR 0.32, 95% CI 0.11, 0.95; P=0.039) and adherence ≥80% (OR 0.39, 95% CI 0.15, 0.99; P=0.047) showed a decreased risk of cognitive impairment. Conclusions: A high prevalence of ANI was observed in virologically suppressed HIV-infected individuals. The revCPE rank showed improved association with neurocognitive dysfunction over the orCPE rank. Moreover, a relationship between cognitive impairment and adherence to antiretroviral therapy was found.

This publication has 31 references indexed in Scilit: